You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 649 Incidence of thromboembolism (TE) in patients with melanoma receiving immune checkpoint inhibitor (ICI) therapy and its adverse impact on survival

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Immunotherapy toxicities
649 Incidence of thromboembolism (TE) in patients with melanoma receiving immune checkpoint inhibitor (ICI) therapy and its adverse impact on survival

 

Online download statistics by month:

Online download statistics by month: November 2020 to March 2024

AbstractFullPdf
Nov 202010207
Dec 20204205
Jan 20212402
Feb 20212804
Mar 202130010
Apr 20214204
May 2021202
Jun 2021005
Jul 20210011
Aug 2021008
Sep 2021006
Oct 202136026
Nov 202116017
Dec 20211000
Jan 20222004
Feb 20222004
Mar 2022802
Apr 20224202
May 202222010
Jun 20221805
Jul 20223806
Aug 20223202
Sep 20221607
Oct 2022805
Nov 20221401
Dec 20222001
Jan 2023803
Feb 20232402
Mar 2023801
Apr 20231001
May 2023602
Jun 20232403
Jul 20231006
Aug 20231407
Sep 20232403
Oct 20231404
Nov 20232204
Dec 20233402
Jan 20241401
Feb 20241203
Mar 202420026
Total8340224